Wednesday, August 22, 2012 6:06:16 AM
NGEN .014 http://stockcharts.com/c-sc/sc?s=NGEN&p=d&b=22&g=0&id=p17970548896
Very telling if you ask me http://www.profitspi.com/stock/view.aspx?v=price-and-chart&p=17791&i=NGEN&pv=recent-symbols&pp=NGEN
http://www.prweb.com/releases/cardiovascular_disease/diagnostics_in_vitro_vivo/prweb8153547.htm
Major players profiled in the report include Abbott Diagnostics, Alere Inc., Beckman Coulter, Inc., Cholestech Corp., GE HealthCare, Nanogen Inc., Philips Medical Systems, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., St Jude Medical Inc., among others.
One might dismiss NGEN as a major player, but I would not dismiss their assets at this time.
The last time they reported was Feb 2010 http://www.otcmarkets.com/stock/NGEN/filings
The above news release, which included Abbott Diagnostics Inc. operates as a subsidiary of Abbott Laboratories at $65.00 a share, and other household names.
More importantly scan back and read PPS going forward, what do you see? http://www.profitspi.com/stock/view.aspx?v=price-and-chart&p=17791&i=NGEN&pv=recent-symbols&pp=NGEN#&&vs=634812260254860788
I'd say this company is NOT dead due too all collectable data... http://www.otcmarkets.com/stock/NGEN/filings
All indicators lead too a leak and/or an announcement.
The article was Feb 2011 of course but that doesn't change NGENs intellectual property. http://www.prnewswire.com/news-releases/nanogen-expands-intellectual-property-surrounding-technologies-for-genetic-analysis-54211162.html
More times than not smaller company can stay ahead of the IP curve in which major companies are moving, thus over time making their patents become extremely important down the road.
Just look at what NEOM has now
In micro-caps it's all about what we have, that major players within said industry don't have, and may need one day.
If I see a tightening of Bid/Ask w/volume I'll be a small buyer today.
Fragmenting one piece of data above having more power over the other is not how I think.... lol
The ol holistic approach
We'll see,
sc
Very telling if you ask me http://www.profitspi.com/stock/view.aspx?v=price-and-chart&p=17791&i=NGEN&pv=recent-symbols&pp=NGEN
http://www.prweb.com/releases/cardiovascular_disease/diagnostics_in_vitro_vivo/prweb8153547.htm
Major players profiled in the report include Abbott Diagnostics, Alere Inc., Beckman Coulter, Inc., Cholestech Corp., GE HealthCare, Nanogen Inc., Philips Medical Systems, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., St Jude Medical Inc., among others.
One might dismiss NGEN as a major player, but I would not dismiss their assets at this time.
The last time they reported was Feb 2010 http://www.otcmarkets.com/stock/NGEN/filings
The above news release, which included Abbott Diagnostics Inc. operates as a subsidiary of Abbott Laboratories at $65.00 a share, and other household names.
More importantly scan back and read PPS going forward, what do you see? http://www.profitspi.com/stock/view.aspx?v=price-and-chart&p=17791&i=NGEN&pv=recent-symbols&pp=NGEN#&&vs=634812260254860788
I'd say this company is NOT dead due too all collectable data... http://www.otcmarkets.com/stock/NGEN/filings
All indicators lead too a leak and/or an announcement.
The article was Feb 2011 of course but that doesn't change NGENs intellectual property. http://www.prnewswire.com/news-releases/nanogen-expands-intellectual-property-surrounding-technologies-for-genetic-analysis-54211162.html
More times than not smaller company can stay ahead of the IP curve in which major companies are moving, thus over time making their patents become extremely important down the road.
Just look at what NEOM has now
In micro-caps it's all about what we have, that major players within said industry don't have, and may need one day.
If I see a tightening of Bid/Ask w/volume I'll be a small buyer today.
Fragmenting one piece of data above having more power over the other is not how I think.... lol
The ol holistic approach
We'll see,
sc
Best iBox Trading Strategy >>> http://investorshub.advfn.com/boards/board.aspx?board_id=18631
**** We don't follow the crowd ****
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
